Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner
Authors:
- Chisato SumiCSChisato Sumi
- Akihisa OkamotoAOAkihisa Okamoto
- Hiromasa TanakaHTHiromasa Tanaka
- Kenichiro NishiKNKenichiro Nishi
- Munenori KusunokiMKMunenori Kusunoki
- Tomohiro ShojiTSTomohiro Shoji
- Takeo UbaTUTakeo Uba
- Yoshiyuki MatsuoYMYoshiyuki Matsuo
- Takehiko AdachiTATakehiko Adachi
- Jun-Ichi HayashiJHJun-Ichi Hayashi
- Keizo TakenagaKTKeizo Takenaga
- Kiichi HirotaKiichi Hirota
Preprint
Abstract
The intravenous anesthetic propofol (2,6-diisopropylphenol) has been used for the induction and maintenance of anesthesia in operating rooms and for sedation in intensive care units. Although there is no widely accepted definition of propofol infusion syndrome (PRIS), PRIS is defined as the development of metabolic acidosis, rhabdomyolysis, hyperkalemia, hepatomegaly, renal failure, arrhythmia, and progressive cardiac failure. In vitro evidence suggests that PRIS is related to the impaired mitochondrial function. There are indications that preexisting mitochondrial disorders predispose to PRIS. However, the precise molecular mechanisms, including mitochondrial defects and a metabolic conversion by propofol, are largely unknown as yet. To elucidate the underlying cellular and molecular mechanisms of PRIS, we investigated the effects of propofol on the cellular metabolic mode and cell death. We demonstrated that clinically relevant concentrations of propofol, used within a clinically relevant exposure time, suppressed the mitochondrial function, caused the generation of reactive oxygen species, and induced a metabolic switch, from oxidative phosphorylation to glycolysis, by targeting complexes I and III of mitochondria. The data also indicated that a predisposition to mitochondrial dysfunction, caused by a genetic mutation or pharmacological suppression of the electron transport chain by biguanides such as metformin and phenformin, promoted the cell death and caspase activation induced by propofol.Keywords
All Related Versions
- Published version: PLOS ONE, 13 (2), e0192796.
This publication has 49 references indexed in Scilit:
- Propofol Is Mitochondrion-Toxic and May Unmask a Mitochondrial DisorderJournal of Child Neurology, 2016
- Anesthetic considerations in patients with mitochondrial defectsPediatric Anesthesia, 2013
- Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2Physiological Reviews, 2012
- Sevoflurane and propofol depolarize mitochondria in rat and human cerebrocortical synaptosomes by different mechanismsActa Anaesthesiologica Scandinavica, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Propofol infusion syndromeAnaesthesia, 2007
- Propofol infusion syndrome in childrenPediatric Anesthesia, 1998
- Mechanisms of Inhibition and Uncoupling of Respiration in Isolated Rat Liver Mitochondria by the General Anesthetic 2,6‐DiisopropylphenolEuropean Journal of Biochemistry, 1996
- Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.BMJ, 1992
- Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondriaArchives of Biochemistry and Biophysics, 1991